BioStem Technologies Operating Expenses Growth & History (BSEM)

BioStem Technologies's operating expenses was $45.1M for fiscal 2025.

View full BioStem Technologies company overview

BioStem Technologies annual operating expenses history

BioStem Technologies annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$45.1M$20.3M+82.03%
20242024-12-31$24.8M$1.6M+6.84%
20232023-12-31$23.2M$12.5M+117.37%
20222022-12-31$10.7M$6.2M+138.72%
20212021-12-31$4.5M

BioStem Technologies operating expenses trends

Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's operating expenses increased from $4.5M to $45.1M, a change of $40.7M. The latest reported quarter, Q2 2026, shows $13.2M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioStem Technologies source filings ↗

Community posts

It’s quiet here.

No posts about BSEM yet. Start the conversation.

Write the first post